Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 241 to 250 of 1532

TitleReference numberPublishedLast updated
Tixagevimab plus cilgavimab for preventing COVID-19TA900
YOURmeds for medication support in long-term conditionsMIB289
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphomaTA894
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapyTA895
Bulevirtide for treating chronic hepatitis DTA896
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist careDG48
Atopic eczema in under 12s: diagnosis and managementCG57
Daratumumab with bortezomib and dexamethasone for previously treated multiple myelomaTA897
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)TA899

Results per page

  1. 10
  2. 25
  3. 50
  4. All